Michael J. Reardon1, MD; Martin B. Leon2, MD; Jeffrey J. Popma3, MD; Michael J. Mack4, MD
1. Houston Methodist Hospital, Houston, TX, USA; 2. NewYork-Presbyterian Columbia University Medical Center, New York, NY, USA; 3. Beth Israel Deaconess Medical Center, Boston, MA, USA; 4. Baylor Scott & White Heart Hospital Plano, Plano, TX, USA
The management of all diseases can range from the simple to the very complex. This holds true for cardiovascular diseases with a tendency to favour the complex end of the spectrum. The concept of treating complex disease with the input of a multidisciplinary team is not new. The care and management of malignant diseases and organ transplantation has long used such multidisciplinary teams to achieve appropriate diagnosis, treatment planning and execution. In the cardiovascular world this was highlighted by the use of Heart Teams in the SYNTAX trial and the benefit seen from this approach1. In both the oncology ...
